Chemo Pharma Laboratories Ltd - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
INTIMATION OF ISSUE OF DUPLICATE SHARE CERTIFICATE UNDER REGULATION 39 (3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Chemo Pharma Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Chemo Pharma Laboratories Ltd - 506365 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Chemo Pharma Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Financial Results For The Quarter Ended 31.12.2018
Submission of Un-audited Financial Results for the quarter ended 31.12.2018 Chemo Pharma Laboratories Ltd - 506365 - Outcome of Board Meeting
Submission of Outcome of Board Meeting held on 28.01.2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Closure of Trading Window CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for 1.To Consider And Approve The Un-Audited Financial Results For The Quarter Ended 31St December, 2018. 2.To Place And Take On Record The Limited Review Report On Un-Audited Financial Results For The Quarter Ended 31St December, 2018. 3.To Place And Take On Record Resignation Of Shri. Prakash Chand Jain From The Position Of Directorship Of The Company. 4.To Place And Take On Record Consent Letter Received From Shri. Mathura Prasad Sharma For Getting Appointed As An Additional Director Of The Company. 5.To Consider Consent Letter Received From M/S. S. K. Jain & Co., Practicing Company Secretaries For Appointment Of Secretarial Auditor Of The Company For The Financial Year 2018-2019.
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2019 ,inter alia, to consider and approve 1.To consider and approve the Un-Audited Financial Results for the Quarter ended 31st December, 2018. 2.To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended 31st December, 2018. 3.To place and take on record resignation of Shri. Prakash Chand Jain from the position of Directorship of the Company. 4.To place and take on record consent letter received from Shri. Mathura Prasad Sharma for getting appointed as an Additional Director of the Company. 5.To consider consent letter received from M/s. S. K. Jain & Co., Practicing Company Secretaries for appointment of Secretarial Auditor of the Company for the Financial Year 2018-2019. CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended December 31, 2018
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Chemo Pharma Laboratories Ltd - 506365 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ashok SomaniDesignation :- Director Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2018
Submission of Un-Audited Financial Results for the quarter and half year ended 30.09.2018